About Reticulophagy regulator 3
Reticulophagy regulator 3 (RETREG3) is a protein
from Homo sapiens identified by UniProt accession
Q86VR2, 466 residues long.
MolForge cross-references it against 0 known binders and
89 disease associations.
Target properties
| Protein name | Reticulophagy regulator 3 |
| UniProt accession | Q86VR2 |
| Gene | RETREG3 |
| Organism | Homo sapiens |
| Length | 466 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (89)
Diseases linked to this target (Open Targets).
- Genetic central nervous system malformation · score 0.40
- genetic disorder · score 0.15
- type 2 diabetes mellitus · score 0.09
- leukocyte count · score 0.09
- lymphocyte count · score 0.09
- apolipoprotein A 1 measurement · score 0.08
- monocyte count · score 0.08
- body weight · score 0.08
- C-reactive protein measurement · score 0.07
- base metabolic rate measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86VR2-F1 | alphafold | PREDICTED | 60.99 | — |
Amino-acid sequence (466 residues)
MAEAEGVPTT PGPASGSTFR GRRDVSGSWE RDQQVEAAQR ALVEVLGPYE PLLSRVQAAL VWERPARSAL WCLGLNAAFW FFALTSLRLV FLLAFGLMII VCIDQWKNKI WPEIKVPRPD ALDNESWGFV HPRLLSVPEL CHHVAEVWVS GTIFIRNVLL FKKQNPGKFC LLSCGILTFL AVLGRYVPGL LLSYLMLVTV MMWPLAVYHR LWDRAYVRLK PALQRLDFSV RGYMMSKQRE RQLRRRALHP ERAMDNHSDS EEELAAFCPQ LDDSTVAREL AITDSEHSDA EVSCTDNGTF NLSRGQTPLT EGSEDLDGHS DPEESFARDL PDFPSINMDP AGLDDEDDTS IGMPSLMYRS PPGAEEPQAP PASRDEAALP ELLLGALPVG SNLTSNLASL VSQGMIQLAL SGASQPGPSG APAQRATRGF LRSPSSDLDT DAEGDDFELL DQSELSQLDP ASSRSH
Explore Reticulophagy regulator 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets